ZIMMER BIOMET HOLDINGS INC (ZBH)
US98956P1021 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 393.00M | 415.80M | 375.70M | 478.50M | 802.00M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.45B | 1.44B | 1.38B | 1.40B | 1.45B | |||
| Inventories | 2.39B | 2.39B | 2.15B | 2.39B | 2.45B | |||
| Other Current Assets | 403.90M | 732.20M | 522.90M | 607.10M | 378.00M | |||
| Total Current Assets | 4.63B | 4.61B | 4.43B | 4.88B | 5.08B | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.09B | 2.26B | 2.07B | 2.29B | 2.32B | |||
| Goodwill | 8.79B | 8.82B | 8.58B | 9.19B | 9.26B | |||
| Intangibles | 4.73B | 4.86B | 5.06B | 6.30B | 7.06B | |||
| Other Non-Current Assets | 1.20B | 948.30M | 925.80M | 791.70M | 695.00M | |||
| Total Non-Current Assets | 16.82B | 16.89B | 16.64B | 18.57B | 19.34B | |||
| TOTAL ASSETS | 21.45B | 21.50B | 21.07B | 23.46B | 24.42B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 970.00M | 900.00M | 544.30M | 1.61B | 500.00M | |||
| Accrued Expenses | N/A | 1.10B | 971.50M | 1.16B | 1.28B | |||
| Accounts Payable | 370.30M | 410.60M | 354.10M | 351.20M | 330.00M | |||
| Other Current Liabilities | 1.46B | 449.10M | 488.30M | 350.00M | 442.00M | |||
| Total Current Liabilities | 2.80B | 2.86B | 2.36B | 3.47B | 2.56B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.83B | 4.87B | 5.15B | 5.46B | 7.63B | |||
| Deferred Taxes/Income | 370.40M | 357.60M | 474.80M | 665.60M | 790.00M | |||
| Other Non-Current Liabilities | 852.80M | 925.90M | 1.05B | 1.19B | 1.25B | |||
| Total Non-Current Liabilities | 6.06B | 6.16B | 6.69B | 7.33B | 9.67B | |||
| TOTAL LIABILITIES | 8.85B | 9.02B | 9.05B | 10.80B | 12.22B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 10.51B | 10.38B | 9.56B | 10.29B | 10.09B | |||
| Additional Paid In Capital | 9.95B | 9.85B | 9.50B | 9.31B | 9.12B | |||
| Minority Interest | 7.70M | 6.60M | 5.70M | 5.20M | 3.50M | |||
| Common Shares | 3.20M | 3.20M | 3.10M | 3.10M | 3.00M | |||
| Treasury Stock | -7.65B | -7.56B | -6.87B | -6.72B | -6.72B | |||
| Other Shareholders' Equity | -211.30M | -191.10M | -179.30M | -231.60M | -298.00M | |||
| Shares Outstanding | 205.70M | 205.60M | 209.00M | 209.00M | 208.00M | |||
| Tangible Book Value per Share | -4.51 | -5.81 | -7.77 | -13.55 | -19.83 | |||
| Total Shareholders' Equity | 12.60B | 12.48B | 12.02B | 12.66B | 12.19B | |||
| TOTAL LIABILITIES AND EQUITY | 21.45B | 21.50B | 21.07B | 23.46B | 24.42B | |||
| Statistics | ||||||||
| Debt/Equity | 0.38 | 0.39 | 0.43 | 0.43 | 0.63 | |||
| Current Ratio | 1.66 | 1.61 | 1.88 | 1.41 | 1.99 | |||
| Return On Assets (ROA) | 4.49% | 4.76% | 1.10% | 1.71% | -0.57% | |||
| Return On Equity (ROE) | 7.65% | 8.20% | 1.93% | 3.17% | -1.14% | |||
| Return On Invested Capital (ROIC) | 6.72% | 6.65% | 5.51% | 4.45% | 2.88% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 6.87% | 6.80% | 5.62% | 4.56% | 2.99% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 26.47% | 27.23% | 21.99% | 22.15% | 13.28% | |||
All data in USD